April 27, 2009
Vitamin D may help treat prostate cancer
Vitamin D cut prostate specific antigen levels, used to mark the seriousness of prostate cancer, by some 50 percent in some subjects, British researchers said.
Study leader Jonathan Waxman Imperial College London said vitamin D2 was taken on a daily basis by 26 patients with prostate cancer and five patients showed improvement, Healthcare Today reported.
The study, published in BJU International, said two patients' PSA levels went down by more than 50 percent, two had decreased levels of between 25 percent and 50 percent, and one had a decrease of less than 25 percent.
It's very interesting -- there has been no significant trial of vitamin D, Waxman said in a statement.
This is a treatment which is unlikely to have significant toxicity and is a welcome addition to the therapeutic options for patients with prostate cancer.